Tekla Life Sciences Investors (NYSE:HQL) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC raised its position in Tekla Life Sciences Investors (NYSE:HQL) by 12.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 44,571 shares of the company’s stock after acquiring an additional 5,065 shares during the period. Janney Montgomery Scott LLC owned approximately 0.20% of Tekla Life Sciences Investors worth $673,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HQL. Steward Partners Investment Advisory LLC purchased a new position in shares of Tekla Life Sciences Investors in the 2nd quarter valued at about $47,000. Winslow Evans & Crocker Inc. purchased a new position in Tekla Life Sciences Investors during the 3rd quarter valued at about $180,000. NEXT Financial Group Inc purchased a new position in Tekla Life Sciences Investors during the 2nd quarter valued at about $233,000. First Trust Advisors LP purchased a new position in Tekla Life Sciences Investors during the 2nd quarter valued at about $328,000. Finally, Atlantic Union Bankshares Corp purchased a new position in Tekla Life Sciences Investors during the 2nd quarter valued at about $371,000. Institutional investors and hedge funds own 12.70% of the company’s stock.

NYSE:HQL traded up $0.10 during mid-day trading on Tuesday, hitting $16.61. 2,731 shares of the company’s stock traded hands, compared to its average volume of 86,385. The firm’s 50 day simple moving average is $15.48 and its 200 day simple moving average is $16.02. Tekla Life Sciences Investors has a 1 year low of $13.95 and a 1 year high of $18.20.

Tekla Life Sciences Investors Company Profile

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.

Recommended Story: Institutional Investors

Institutional Ownership by Quarter for Tekla Life Sciences Investors (NYSE:HQL)

Receive News & Ratings for Tekla Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.